Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Marimed (MRMD) Long-Term Debt Issuances (2016 - 2025)

Marimed (MRMD) has disclosed Long-Term Debt Issuances for 11 consecutive years, with $2.0 million as the latest value for Q2 2025.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A to $2.0 million in Q2 2025 year-over-year; TTM through Sep 2025 was $837000.0, a 28.03% decrease, with the full-year FY2023 number at $29.1 million, changed N/A from a year prior.
  • Long-Term Debt Issuances was $2.0 million for Q2 2025 at Marimed, up from -$1.2 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $29.1 million in Q3 2023 to a low of -$1.2 million in Q4 2024.
  • A 4-year average of $6.8 million and a median of $2.0 million in 2025 define the central range for Long-Term Debt Issuances.
  • Biggest YoY gain for Long-Term Debt Issuances was 161.76% in 2021; the steepest drop was 161.76% in 2021.
  • Marimed's Long-Term Debt Issuances stood at $2.7 million in 2021, then soared by 991.93% to $29.1 million in 2023, then crashed by 104.0% to -$1.2 million in 2024, then soared by 271.97% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Long-Term Debt Issuances are $2.0 million (Q2 2025), -$1.2 million (Q4 2024), and $1.2 million (Q1 2024).